The safety of thrombolytic therapy of acute myocardial infarction could be improved if a method were developed to dissolve fresh occlusive coronary thrombus without simultaneously dissolving hemostatic thrombi outside the coronary arteries. This study is based on the assumption that, in a patient with evolving acute myocardial infarction, hemostatic thrombi are likely to be older than the thrombus responsible for occlusion of the coronary artery. It explored whether the relative rates of lysis of fresh and old thrombi could be influenced by the rapidity of recombinant tissuetype plasminogen activator @t-PA) administration.
In each of 17 dogs, two 1 h and two 24 h old thrombi were produced by inserting copper coils into both jugular and both femoral veins. After 24 h and 1 h, respectively, the coils with the thrombi were removed, weighed and inserted into the adjacent carotid and femoral arteries. A 1 mg/kg body weight dose of r&PA was given either over 180 or over 30 min. The coils were removed and weights of the residual thrombi determined at the end of the 180 min infusion (Group I), at the end of the 30 min infusion (Group HA) and 45 min after the 30 min infusion (Group IIB). The 24 h old thrombi were lysed significantly less than the 1 h old thrombi in all three experimental groups: 53.9 f 4.8% (mean + SE) versus 86.1 + 2.5% in Group I (p < O.OOl), 16 .6 + 3.5% versus 65.2 f 6.0% in Group IIA (p < 0.001) and 21.6 + 5.4% versus 91.7 + 1.7% in Group IIB (p < 0.001). The 24 h old thrombi were also lysed significantly less by the 30 min infusion than by the 180 min infusion (p < 0.001 for both). The ratio of lysis of 1 and 24 h old thrombi was markedly higher in Groups IIA (7.95 + 2.16) and IIB (6.52 * 1.50) than in Group I(l.71 * 0.17) (p < 0.01 for both).
These findings suggest that r&PA administered rapidly over a shorter period is less likely to lyse older thrombus, whereas the effect on fresh thrombus is preserved and probably enhanced. Clinical studies are needed to confirm the conclusions of this experimental study. It is now generally recognized that thrombolytic therapy of acute myocardial infarction restores myocardial perfusion (1,2), preserves ventricular function (3-5) and reduces mortality (6,7). The value of thrombolytic therapy is diminished by relatively frequent bleeding, resulting in significant morbidity and infrequently in death. The risk of serious bleeding also leads to exclusion of a great number of patients who may otherwise benefit from thrombolytic therapy. Bleeding during or early after thrombolytic therapy of acute myocardial infarction has been attributed to lysis of hemostatic thrombi protecting defects in the vessel wall outside the coronary circulation (8) . Hemostatic thrombi are likely to be older than the thrombus that caused or completed the occlusion of the coronary artery and thereby triggered the ongoing acute myocardial infarction. If so, the probability of serious bleeding could be reduced by a method that would allow lysing fresh coronary thrombus without lysing older hemostatic thrombi. In this study, we explored whether the relative rates of lysis of fresh and old thrombi could be influenced by the rapidity of recombinant tissue-type plasminogen activator @-PA) administration.
Methods
The animals used in this study were maintained in accordance with the guidelines of the Experimental thrombus production. The study was performed in 17 closed chest mongrel dogs weighing 15 to 32 kg (average 23.2) and anesthetized with 30 mg/kg body weight of sodium pentobarbital and additional small doses as needed to maintain 24 h of stable anesthesia. The dogs were intubated and artificially ventilated with use of a Harvard respirator. The external jugular and the femoral veins were exposed randomly, first on one side and 23 h later on the other side. For induction of thrombosis (9) , four helically shaped copper coils, 25 mm in length and 2 mm in internal diameter, were used; they were stripped of their insulation and made thrombogenic by brief immersion into sulfuric acid. The coils were weighed and then inserted into the dissected veins, two initially and two 23 h later. Thrombus formation usually began within minutes after insertion of the coils. Twenty-four hours after insertion of the first pair of coils and 1 h after insertion of the second pair of coils, all four coils were retrieved from the veins, weighed again to determine the initial weights of thrombi and then inserted into the freshly dissected adjacent carotid and femoral arteries. The thrombi were solid and firmly adhered to the coil.
A predominantly single chain form of recombinant tissuetype plasminogen activator (rt-PA) was administered according to three protocols. (The drug was kindly supplied by Genentech Inc.) At the end of the study, the coils were removed from the arteries and weighed again to determine the weights of the residual thrombi. The degree of lysis was expressed as a percent decrease in initial thrombus weight, and calculated as the difference between the initial and the residual weight divided by the initial weight. An electrocardiographic (ECG) lead and systemic arterial pressure were continuously monitored.
Study protocol. With all four coils in place in the arteries, t-t-PA was administered intravenously in a total dose of 1 mglkg over either 180 or 30 min; 10% of the total dose was given as an initial bolus. The 1 mg/kg dose of t-t-PA was similar to the dosage applied in human studies (10,l l), although not necessarily equivalent in effect. Three groups of dogs were studied.
In Group I Cfive dogs), the 1 mg/kg dose of rt-PA was administered over 180 min at a rate of 5 CLglkg/min after an initial 100 CLg/kg bolus. The coils were retrieved from the arteries, and the degree of lysis was determined immediately after the infusion.
Group II (12 dogs) received the 1 mglkg dose of &PA over a period of 30 min at a rate of 30 pg/kg/min after an initial 100 pg/kg bolus. In Subgroup IIA (seven dogs), the coils were retrieved and the degree of lysis was determined immediately after the infusion. In Subgroup IIB (five dogs), the coils were removed and the degree of lysis was determined 45 min after the end of the infusion, by which time the plasma concentration of rt-PA had decreased to ~7% of its peak value.
Plasma concentrations of r&PA. Plasma samples for the determination of t-t-PA levels were taken before and at 30, 120 and 180 min during the infusion in Group I, before and at I5 and 30 min during the infusion in Group HA and before and at 15 and 30 min during the infusion and at 30 and 45 min after the infusion in Group IIB. An enzyme-linked immunosorbent assay (ELISA) based on monoclonal antibodies was used to measure the concentration of rt-PA (12) . The analysis of the rt-PA concentration was performed in the laboratories of the Department of Biochemistry of the University of Vermont, College of Medicine.
Statistical analysis. A general mixed model analysis of variance was used to test the effects of thrombus age, length of infusion or type of artery on the rate of lysis. This method of analysis was chosen to allow for multiple measurements within each animal. Pre-to postinfusion changes were assessed by paired t test. All statistical tests were performed with BMDP biostatistical software (13) . A p value of <0.05 was considered to indicate a statistically significant difference. All data are presented as mean 2 SEM.
Results
Sixty-eight coils were initially implanted in the 17 dogs. Eight coils could not be studied (six could not be retrieved from the vein and two could not be reinserted into the artery). Of these eight coils, two each were in Groups I and IIB and four in Group IIA. Thirty 1 h and thirty 24 h old thrombi were available for analysis.
Initial thrombus weight (Table 1 ). The weight of 1 h old thrombi ranged from 81.6 to 193.0 mg (average 143.1 ? 7.0 in Group I, 140.0 ? 8.4 in Group IIA and 153.1 ? 7.0 in Group IIB). The weight of 24 h old thrombi ranged from 121.6 to 182.6 mg (average 159.1 ? 4.9 in Group I, 153.5 -t 6.5 in Group IIA and 166.8 ? 2.9 in Group IIB). The initial weights of 1 and 24 h old thrombi were not significantly different among the three groups. There was also no significant difference between the weights of 1 and 24 h old thrombi in any of the three groups.
Lysis of thrombi after r&PA (Table 1 ). The weight of 1 h old thrombi decreased by 86.1 ? 2.5% after administration of rt-PA over 180 min in Group I, by 65.2 2 6.0% by the end of the 30 min infusion in Group IIA and by 91.7 4 1.7% by 45 min after the end of the 30 min infusion in Group IIB. The decrease in Group IIA was significantly smaller than that in Group I or Group IIB (p < 0.05 for both); this difference was obviously due to removal of the coil with the thrombus immediately after the rapid infusion when the plasma concentration of rt-PA was still very high.
The weight of 24 h old thrombi decreased by 53.9 2 4.8% The lysis of 24 h old thrombi was significantly greater when the 1 mg/kg dose of rt-PA was infused over 180 min than after infusion of the same dose over 30 min in Group IIA or IIB, both in absolute terms (p < 0.001 for both) and relative to lysis of 1 h old thrombi in the same experiment (Fig. 1) . The relation between lysis of 1 and 24 h old thrombi in the same experiment is expressed in Table 1 as the ratio of lysis of the 1 and 24 h old thrombi from the same experiment. The ratio was significantly higher at the end as well as 45 min after the 30 min infusion of rt-PA than after its infusion over 180 min (p < 0.01 for both).
Appearance and histologic features of thrombi. Twentyfour hour old thrombi appeared darker and had a firmer The differential effect of the rapidity of r&PA administration on lysis of fresh and old thrombi. The relations between the lysis of 1 and 24 h old thrombi in the three protocol groups. Group I = 100 pg/kg bolus of r&PA, followed by 5 pg/kg per min infusion for 180 min; Group IIA and IIB = 100 I.Lg/kg bolus of r&PA, followed by 30 cLg/kg per min infusion for 30 min. In Group IIA, the degree of lysis was determined immediately after the infusion. In Group IIB, the degree of lysis was determined 45 min after the infusion.
consistency than did 1 h old thrombi. For histologic studies, thrombi were fixed in formalin, and processed routinely for evaluation. Hematoxylin-eosin-stained sections from longitudinally oriented thrombi were evaluated for the degree of separation of blood components into bands of erythrocytes, leukocytes and platelets-fibrin (lines of Zahn). In addition, fibrin bands were classified as being either dense or loose, on the basis of how compact and distinct these bands were in relation to other components of the thrombi. Twenty-four hour old thrombi tended to have more distinct layering of blood components and more compact dense fibrin bands than did 1 h old thrombi; however, some overlap of findings was observed.
Plasma levels of r&PA (Table 2) . Peak plasma levels were about five times higher after the 30 min administration compared with the 180 min administration, and rapidly decreased after termination of the infusion.
Discussion
Effect of tbrombus age on resistance to lysis. In agreement with previous experimental (14) (15) (16) (17) and clinical studies (18, 19) , older thrombi were more resistant to lysis than were fresh thrombi. The increased resistance of older thrombi to lysis was present during both rapid and slow administration of rt-PA in this study. However, older thrombi were lysed to a significantly greater extent when the same 1 mg/kg dose of rt-PA was given over 180 rather than 30 min. There is no direct evidence to explain why older thrombi are lysed more when the rt-PA dose is administered more slowly over a longer period of time. The explanation may be that older thrombi have a higher density (20) , due to continuing polymerization and crosslinking of fibrin (21) (22) (23) (24) (25) , and may therefore be less penetrable to r&PA and require longer exposure to undergo the same degree of lysis.
Potential clinical implications. Our study assumed that hemostatic thrombi that protect vascular defects (in the brain, gastrointestinal tract or elsewhere outside the coronary circulation) are likely to be older than the portion of the thrombus that completed the occlusion of the coronary artery in a patient with evolving acute myocardial infarction. Thus, the finding that rapid administration of t-t-PA appears less likely to cause dissolution of older thrombi while maintaining and probably enhancing the capacity to lyse fresh thrombi could be of great importance if confirmed under clinical conditions. A marked reduction in wound bleeding coupled with significant enhancement of thrombus lysis was observed by Agnelli et al. (26) when rabbits with experimental jugular vein thrombosis received a given dose of &PA over a shorter period of time. In patients, a decrease in the frequency of bleeding complications and an increase in infarct-related patency rate of the artery were reported by Top01 et al. (27) when the 150 mg dose of r&PA was given over 5 rather than 7 h. Administration of a 150 mg dose of rt-PA over a period of only 2 h by Lew et al. (28) was associated with a low frequency of major bleeding complications and a high rate of infarct-related artery patency. Thadani (29) observed that prolonged administration of a given dose of the double chain form of rt-PA was associated with a significantly increased risk of serious bleeding complications.
In light of recent reports (30,31), it may seem that the effort to reduce serious bleeding complications and to enhance lysis of coronary thrombus by accelerated administration of rt-PA may be in conflict with efforts to prevent reocclusion after successful reperfusion of a coronary artery. Gold et al. (30) and Johns et al. (31) reported that a 4 h maintenance infusion of rt-PA can prevent reocclusion of the reopened infarct-related artery. However, because their study groups received not only longer infusions of rt-PA but also a considerably larger dose of rt-PA administered during the maintenance infusion, it cannot be ruled out that the lower reocclusion rate was due to the higher total dose of rt-PA rather than to the longer infusion. That possibility is supported by the finding of Top01 et al. (27) that shortening of the duration of infusion of the same dose of rt-PA from 7 to 5 h resulted, if anything, in a decrease rather than an increase in the reocclusion rate. The relatively low 10% early reocclusion rate in the study by Lew et al. (28) using a short 2 h infusion of 150 mg of rt-PA also suggests that it may be the higher total dose rather than the protracted administration that helps to reduce the rate of reocclusion. Rapid rt-PA administration may be both safer, and also appears more effective in terms of the frequency and rapidity of coronary reperfusion (27) .
It appears, therefore, that accelerated administration of rt-PA and possibly other plasminogen activators may improve both the safety and the efficacy of thrombolytic therapy. Clinical investigations are needed to confirm the conclusions of this experimental study.
